Deutsche Bank’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-1,104
| Closed | -$5K | – | 5383 |
|
|
2016
Q4 | $5K | Sell |
1,104
-17,928
| -94% | -$84.3K | ﹤0.01% | 4763 |
|
|
2016
Q3 | $88K | Buy |
19,032
+17,782
| +1,423% | +$83K | ﹤0.01% | 3989 |
|
|
2016
Q2 | $4K | Hold |
1,250
| – | – | ﹤0.01% | 5046 |
|
|
2016
Q1 | $3K | Sell |
1,250
-16,645
| -93% | -$55.8K | ﹤0.01% | 5033 |
|
|
2015
Q4 | $81K | Sell |
17,895
-79,294
| -82% | -$376K | ﹤0.01% | 4163 |
|
|
2015
Q3 | $457K | Sell |
97,189
-99,287
| -51% | -$641K | ﹤0.01% | 3409 |
|
|
2015
Q2 | $1.41M | Buy |
196,476
+102,611
| +109% | +$772K | ﹤0.01% | 2736 |
|
|
2015
Q1 | $794K | Buy |
93,865
+22,856
| +32% | +$195K | ﹤0.01% | 3016 |
|
|
2014
Q4 | $660K | Buy |
71,009
+8,951
| +14% | +$77.8K | ﹤0.01% | 3490 |
|
|
2014
Q3 | $516K | Buy |
62,058
+16,775
| +37% | +$155K | ﹤0.01% | 3483 |
|
|
2014
Q2 | $523K | Buy |
45,283
+3,674
| +9% | +$37.7K | ﹤0.01% | 3434 |
|
|
2014
Q1 | $526K | Buy |
41,609
+38,721
| +1,341% | +$501K | ﹤0.01% | 3301 |
|
|
2013
Q4 | $31K | Sell |
2,888
-13,518
| -82% | -$157K | ﹤0.01% | 4572 |
|
|
2013
Q3 | $202K | Buy |
16,406
+8,138
| +98% | +$113K | ﹤0.01% | 4114 |
|
|
2013
Q2 | $109K | Buy |
+8,268
| New | +$106K | ﹤0.01% | 4183 |
|
Other funds holding DSCI
Deutsche Bank's DSCI Position: Q1 2017 in Review
Deutsche Bank sold out of Derma Sciences, Inc. Common Stock (DE) (DSCI) in Q1 2017, closing a stake of 1,104 shares — an estimated $5K sold.
Deutsche Bank first reported a position in DSCI in Q2 2013 and held it in 15 quarters. The position peaked at $1.41M in Q2 2015. 1 fund tracked by Wall St. Rank holds DSCI as of Q1 2017.
- Deutsche Bank reported no remaining Derma Sciences, Inc. Common Stock (DE) position as of Q1 2017 after selling out during the quarter.
- Deutsche Bank sold 1,104 Derma Sciences, Inc. Common Stock (DE) shares in Q1 2017, an estimated $5K.
- Deutsche Bank first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q2 2013 and held it in 15 quarters.
- Deutsche Bank's Derma Sciences, Inc. Common Stock (DE) position peaked at $1.41M in Q2 2015.
- 1 fund tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q1 2017.
Based on Deutsche Bank's 13F filing for Q1 2017, filed 15 May 2017.